6273.T (6273.T)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 7/9, Altman Z 16.9 (above 3.0 safe zone threshold).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental quality of 6273.T is underpinned by a narrow negative ROIC-WACC spread, indicating that the company's return on invested capital falls slightly short of its cost of capital. However, this slight inefficiency is offset by strong financial health metrics such as a high DuPont ROE decomposition, driven largely by robust net margins at 19.7% and an asset turnover ratio of 0.38x, suggesting efficient use of assets to generate sales. The Piotroski F-Score of 7/9 further corroborates the company's financial strength, while the Altman Z-Score of 16.9 signals a very low probability of bankruptcy.
In terms of valuation, the current P/E ratio stands at 26.2x, which is higher than both historical and sector averages, implying that investors are willing to pay more for each unit of earnings compared to past valuations or peers. The DCF fair value estimate suggests an intrinsic worth of $26447 per share, indicating a market price that may be discounted relative to the implied growth rate embedded in this valuation model. This discrepancy could reflect investor expectations regarding future revenue growth at 2%, which is modest and may not fully justify the current premium pricing.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6.7% | 8.7% | 10.7% |
|---|---|---|---|
| 2% | $30587 | $24514 | $21233 |
| 3% | $35181 | $26447 | $22255 |
| 4% | $43214 | $29209 | $23584 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=8.7%, terminal growth 3%. Fair value $26447 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
6273.T Capital Efficiency
How efficiently does 6273.T convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
6273.T converts 36% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 64% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-0.2%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Compare 6273.T to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.